Company intelligence / Profile preview
Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd.
Jiangyin City, Jiangsu, Chinaen.protelight.com ↗
- Ownership
- Private
- Development stage
- Phase 3
01
Overview
Jiangsu ProteLight has developed a robust pipeline centered on first-in-class antimicrobial peptides. Its lead program, peceleganan/PL‑5—a broad-spectrum topical antimicrobial peptide—has completed Phase II trials in the US and China for wound infections and entered preregistration/Phase IIIb in China. Clinical data show good efficacy with minimal systemic exposure. The company also advances additional anti-infective and oncology assets at preclinical to early clinical stages.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Peptide drugs (antimicrobial peptides, peptide therapeutics)Small molecules
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
Request access →03
Partnerships
Exclusive licensing agreement with Sino Biopharmaceutical Limited for certain assets as of January 2023.
Beyond the preview
Go deeper on Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd..